UniSuper Management Pty Ltd Buys 3,323 Shares of CME Group Inc. (NASDAQ:CME)

UniSuper Management Pty Ltd lifted its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 15.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,661 shares of the financial services provider’s stock after acquiring an additional 3,323 shares during the quarter. UniSuper Management Pty Ltd’s holdings in CME Group were worth $5,727,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Truvestments Capital LLC bought a new position in CME Group in the third quarter valued at about $26,000. SJS Investment Consulting Inc. raised its position in CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC boosted its stake in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares during the last quarter. Financial Life Planners bought a new stake in shares of CME Group during the 4th quarter valued at $32,000. Finally, Knuff & Co LLC purchased a new stake in shares of CME Group in the 4th quarter worth $33,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CME shares. Oppenheimer boosted their price target on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Barclays increased their target price on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Finally, Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $238.93.

View Our Latest Stock Analysis on CME

Insider Transactions at CME Group

In other CME Group news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the transaction, the director now directly owns 21,873 shares of the company’s stock, valued at $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,076 shares of company stock worth $6,871,496 in the last three months. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ:CME opened at $261.85 on Friday. The company has a market capitalization of $94.36 billion, a P/E ratio of 27.08, a P/E/G ratio of 6.76 and a beta of 0.53. The business’s 50-day moving average is $249.06 and its 200 day moving average is $235.32. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $267.91.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were paid a $1.25 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date was Friday, March 7th. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group declared that its Board of Directors has approved a share buyback program on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.